Your browser doesn't support javascript.
loading
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
Yamada, Yosuke; Belharazem-Vitacolonnna, Djeda; Bohnenberger, Hanibal; Weiß, Christel; Matsui, Naoko; Kriegsmann, Mark; Kriegsmann, Katharina; Sinn, Peter; Simon-Keller, Katja; Hamilton, Gerhard; Graeter, Thomas; Preissler, Gerhard; Ott, German; Schölch, Sebastian; Nakajima, Naoki; Yoshizawa, Akihiko; Haga, Hironori; Date, Hiroshi; Thomas, Roman K; Petrini, Iacopo; Giaccone, Giuseppe; Ströbel, Philipp; Marx, Alexander.
Afiliación
  • Yamada Y; Institute of Pathology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. yyamada@kuhp.kyoto-u.ac.jp.
  • Belharazem-Vitacolonnna D; Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. yyamada@kuhp.kyoto-u.ac.jp.
  • Bohnenberger H; Institute of Pathology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Weiß C; Institute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
  • Matsui N; Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Kriegsmann M; Institute of Pathology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Kriegsmann K; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Sinn P; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Simon-Keller K; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hamilton G; Institute of Pathology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Graeter T; Institute for Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Preissler G; Thoracic Surgery, Klinik Löwenstein, Löwenstein, Germany.
  • Ott G; Department of Thoracic Surgery, Klinik Schillerhöhe GmbH am Robert-Bosch-Krankenhaus, Stuttgart, Germany.
  • Schölch S; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Nakajima N; Department of Surgery, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
  • Yoshizawa A; Junior Clinical Cooperation Unit Translational Surgical Oncology (A430), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Haga H; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.
  • Date H; Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Thomas RK; Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Petrini I; Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Giaccone G; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ströbel P; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.
  • Marx A; Institute of Pathology, University of Cologne, Cologne, Germany.
Cell Death Dis ; 13(11): 979, 2022 11 19.
Article en En | MEDLINE | ID: mdl-36402755

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Carcinoma de Células Pequeñas / Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Carcinoma de Células Pequeñas / Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: Alemania